Rayner's RayOne EMV Toric IOL received FDA approval after a successful pivotal IDE study, highlighting its rotational ...
Andrew G. Lee, MD, and Drew Carey, MD, highlight how chronic lymphocytic leukemia can mimic Graves’ orbitopathy, underscoring ...
Attendees of the AAO 2025 annual meeting will have a chance to preview the virtual technician training platform on October 19 ...
Epion Therapeutics announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ...
The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...
Avisi Technologies’ investigational device exemption (IDE) submission for its glaucoma treatment device VisiPlate has been approved by the US Food and Drug Administration (FDA).
The Polaris platform is the world’s first AI-supported and robotics-enabled surgical system developed specifically for ...
REGENXBIO completed enrollment in its ATMOSPHERE and ASCENT trials that will be evaluating surabgene lomparvovec (sura-vec, ...
Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...
The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through ...
Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...
The US Food and Drug Administration (FDA) has approved Celltrion’s aflibercept-boav (EYDENZELT) biosimilar referencing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback